Laurion Capital Management LP Denali Therapeutics Inc. Transaction History

Laurion Capital Management LP

  • $7.27 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020
SELL
$16.01 - $28.82 $800,500 - $1.44 Million
-50,000 Closed
0 $0
Q1 2020

May 14, 2020
BUY
$14.2 - $27.98 $710,000 - $1.4 Million
50,000 New
50,000 $876,000
Q2 2018

Aug 13, 2018
SELL
$15.25 - $21.02 $1.81 Million - $2.49 Million
-118,581 Closed
0 $0
Q1 2018

May 14, 2018
BUY
$15.36 - $24.8 $515,804 - $832,808
33,581 Added 39.51%
118,581 $2.34 Million
Q4 2017

Feb 13, 2018
BUY
$15.04 - $21.45 $1.28 Million - $1.82 Million
85,000
85,000 $1.33 Million

Others Institutions Holding DNLI

# of Institutions
227
Shares Held
119M
Call Options Held
60.6K
Put Options Held
48.4K
View Full List

About Denali Therapeutics Inc.

DNLI Quotes by TradingView
  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $2.88B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email